by Marybeth Burke – Some of the most essential mainstays in cancer treatment drugs for adults and children are in short supply, Michael Link, M.D., president of the… read more.
by Marybeth Burke – The investigational drug BMS-936558 caused tumour shrinkage in up to a quarter of patients with advanced melanoma, kidney and NSCLC cancers,
by Marybeth Burke – Afatinib, an irreversible ErbB-family blocker, delays progression of advanced lung cancer in patients with epidermal growth factor receptor (EGFR) mutations compared with standard chemotherapy,
25 Feb 2012 – EAU Paris – Men often finds it difficult to talk with primary health specialists and this is certainly true in the case of BPH.
It is estimated that as many as 24 million European men aged 50 and over experience bothersome urinary symptoms.1,2 Yet, despite experiencing symptoms, men typically wait nearly two… read more.
Second study sheds light on the ‘obesity paradox’ People can be obese but metabolically healthy and fit, with no greater risk of developing or dying from cardiovascular disease… read more.
Second study sheds light on the ‘obesity paradox’ People can be obese but metabolically healthy and fit, with no greater risk of developing or dying from cardiovascular disease… read more.
by Bruce Sylvester – Emerging use of FDA Approved Drugs – Maraviroc, an antiretroviral drugin the treatment of HIV, significantly reduces the incidence of graft-versus-host disease (GvHD) among… read more.
by Bruce Sylvester – taken from The British Medical Journal (BMJ) – Contradicting previous research, researchers from a study of over 44,000 women in England report that treatment… read more.
by Bruce Sylvester – taken from The New England Journal of Medicine (NEJM) – Women treated with anastrozole and fulvestrant combination therapy have achieved over 6 months median… read more.
by Bruce Sylvester – taken from The Lancet – A study by Professor Peter M Rothwell, University of Oxford, UK and colleagues supports the hypothesis and adds to… read more.
by Gary Finnegan – World Health Matters (Sweden) – Breast cancer screening has limited or no impact on breast cancer mortality among women aged 40-69, according to a… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
